Quality of Life Research

, Volume 19, Issue 3, pp 317–322 | Cite as

Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: a prospective study

  • Yu-Tao Xiang
  • Chuan-Yue Wang
  • Ying Wang
  • Helen F. K. Chiu
  • Jing-Ping Zhao
  • Qi Chen
  • Sandra S. M. Chan
  • Edwin H. M. Lee
  • Gabor S. Ungvari
Brief Communication



The aim of the study was to assess the changes in the quality of life (QOL) of Chinese schizophrenia patients and to identify their predictors over a 1-year follow-up.


A cohort of 116 schizophrenia patients was recruited, and their socio-demographic and clinical characteristics including psychotic and depressive symptoms, drug-induced side effects, social functioning, and QOL were assessed with standardized rating instruments. The patients received standard psychiatric care and were followed up for 1 year.


The psychotic and depressive symptoms, extrapyramidal side effects, and QOL domains of physical functioning, role limitations due to physical problems, social functioning, and role limitations due to emotional problems all improved significantly. Social functioning was a predictor of baseline QOL and change at 1-year follow-up.


Routine clinical management was effective in improving schizophrenia patients’ psychopathology and several domains of QOL. QOL was related to the level of social functioning and had only a weak association with socio-demographic factors.


Schizophrenia Quality of life Prospective design Social functioning 



Quality of life


Extrapyramidal side effects


Positive and Negative Syndrome Scale


Montgomery-Åsberg Depression Rating Scale


Simpson-Angus Scale of Extrapyramidal Symptoms


Social Disability Screening Schedule


Physical functioning


Role limitations due to physical problems


Bodily pain


General health




Social functioning


Role limitations due to emotional problems


Mental health



This study was supported by Direct Grant for Research from the Chinese University of Hong Kong (No. 2041454), the National Natural Science Foundation of China (No. 30800367), the Beijing Nova Program of the Beijing Municipal Science and Technology Commission (No. 2008B59), and the 10th National 5-Year Plan Foundation of the Ministry of Science and Technology Program (No. 2004BA720A22).


  1. 1.
    Sartorius, N. (1997). Quality of life, mental disorders: A global perspective. Chichester: John Wiley.Google Scholar
  2. 2.
    Chan, G. W., Ungvari, G. S., Shek, D. T., & Leung Dagger, J. J. (2003). Hospital and community-based care for patients with chronic schizophrenia in Hong Kong—Quality of life and its correlates. Social Psychiatry and Psychiatric Epidemiology, 38, 196–203.CrossRefPubMedGoogle Scholar
  3. 3.
    Law, C. W., Chen, E. Y., Cheung, E. F., Chan, R. C., Wong, J. G., Lam, C. L., et al. (2005). Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Quality of Life Research, 14, 1803–1811.CrossRefPubMedGoogle Scholar
  4. 4.
    Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2008). Socio-demographic and clinical correlates of lifetime suicide attempts and their impact on quality of life in Chinese schizophrenia patients. Journal of Psychiatric Research, 42, 495–502.CrossRefPubMedGoogle Scholar
  5. 5.
    Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2008). Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: Relationship to socio-demographic and clinical factors. Quality of Life Research, 17, 27–36.CrossRefPubMedGoogle Scholar
  6. 6.
    Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., Lai, K. Y., & Ungvari, G. S. (2009). Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients. Sleep, 32, 105–109.PubMedGoogle Scholar
  7. 7.
    He, Y. L., & Zhang, M. Y. (1997). The positive and negative syndrome scale (PANSS) and its application (in Chinese). Journal of Clinical Psychiatry, 7, 353–355.Google Scholar
  8. 8.
    Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.CrossRefPubMedGoogle Scholar
  9. 9.
    Simpson, G. M., & Angus, J. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 212(Supplementum), 11–19.CrossRefGoogle Scholar
  10. 10.
    Wu, W. Y. (1998). Social Disability Screening Schedule-Chinese version. In M. Y. Zhang (Ed.), Handbook of rating scales in psychiatry (pp 163–166). Changsha: Hunan, Hunan Science and Technology Press.Google Scholar
  11. 11.
    Xu, J., Hu, M. Y., Yang, Y. B., Wang, B. H., & Xie, Y. N. (1999). Medical outcome study 36 item short form (SF-36) (in Chinese). Chinese Journal of Behavioral Medical Science, 8, 150–152.Google Scholar
  12. 12.
    Xu, D., & Xu, D. M. (2001). Investigation of marital status for 758 schizophrenics (in Chinese). Zhongyuan Mental Health, 7, 136–139.Google Scholar
  13. 13.
    Guo, Z. Y., Liu, J. M., Zhang, J. Z., Guo, H., & Wang, A. Q. (2008). Efficacy of quetiapine in the treatment of schizophrenic patients and its effect on quality of life (in Chinese). Chinese Journal of Health Psychology, 16, 544–546.Google Scholar
  14. 14.
    Potkin, S. G., Weiden, P. J., Loebel, A. D., Warrington, L. E., Watsky, E. J., & Siu, C. O. (2009). Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. International Journal of Neuropsychopharmacology, 12, 1233–1248.Google Scholar
  15. 15.
    Wegener, S., Redoblado-Hodge, M. A., Lucas, S., Fitzgerald, D., Harris, A., & Brennan, J. (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 39, 487–492.PubMedGoogle Scholar
  16. 16.
    Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., et al. (1996). Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica, 94, 118–124.CrossRefPubMedGoogle Scholar
  17. 17.
    Corrigan, P. W., & Buican, B. (1995). The construct validity of subjective quality of life for the severely mentally ill. Journal of Nervous and Mental Disease, 183, 281–285.PubMedCrossRefGoogle Scholar
  18. 18.
    Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2007). Quality of life of Chinese schizophrenia outpatients in Hong Kong: Relationship to sociodemographic factors and symptomatology. Australian and New Zealand Journal of Psychiatry, 41, 442–449.CrossRefPubMedGoogle Scholar
  19. 19.
    Kwon, J. S., & Choi, J. S. (2009). Social functioning and quality of life as measures of effectiveness in the treatment of schizophrenia. World Psychiatry, 8, 35–36.PubMedGoogle Scholar
  20. 20.
    Trompenaars, F. J., Masthoff, E. D., Van Heck, G. L., De Vries, J., & Hodiamont, P. P. (2007). Relationships between social functioning and quality of life in a population of Dutch adult psychiatric outpatients. International Journal of Social Psychiatry, 53, 36–47.CrossRefPubMedGoogle Scholar
  21. 21.
    Franz, M., Meyer, T., Reber, T., & Gallhofer, B. (2000). The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Quality of Life Research, 9, 481–489.CrossRefPubMedGoogle Scholar
  22. 22.
    Katschnig, H. (2000). Schizophrenia and quality of life. Acta Psychiatrica Scandinavica, 407(Suppl), 33–37.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Yu-Tao Xiang
    • 1
    • 2
  • Chuan-Yue Wang
    • 1
  • Ying Wang
    • 1
  • Helen F. K. Chiu
    • 2
  • Jing-Ping Zhao
    • 3
  • Qi Chen
    • 1
  • Sandra S. M. Chan
    • 2
  • Edwin H. M. Lee
    • 2
  • Gabor S. Ungvari
    • 2
  1. 1.Laboratory of Clinical Psychopharmacology, Beijing Anding HospitalCapital Medical UniversityBeijingChina
  2. 2.Department of PsychiatryChinese University of Hong KongHong KongChina
  3. 3.Mental Health Institute of the Second Xiangya HospitalCentral South UniversityChangshaChina

Personalised recommendations